GlobalData on MSN
MMI wins IDE for surgical robotic Alzheimer’s disease study
MMI’s REMIND study will evaluate its Symani surgical robot in reestablishing lymphatic drainage pathways to treat Alzheimer’s ...
(MMI) announced today that it received FDA investigational device exemption (IDE) to study its microsurgery platform.
Aqua Medical has received investigational device exemption (IDE) from the FDA for its ablation device aimed at treating ...
The feasibility study, entitled REMIND, Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease, will ...
The IDE approval marks a pivotal milestone for Aqua Medical, allowing the company to begin enrolling patients in the U.S. RESTORE-1 pilot trial and study PIMA's potential to deliver durable metabolic ...
Cash and investments are sufficient to fund current operations through Q2 2027, not including VenoValve commercialization and ...
To address that, Cursor introduced Composer alongside its new multi-agent interface, which allows you to “run many agents in ...
XDA Developers on MSN
The minimalist text editor that replaced my over-engineered IDE
For too long, I, like many developers, believed that an over-engineered IDE was a necessity for professional coding. However, ...
1don MSN
Pulse Biosciences targets Q1 completion of PRECISE-BTN study enrollment as clinical adoption grows
Get the latest on Pulse Biosciences’ Q3 2025 earnings: commercial growth, FDA progress, and clinical trial updates in soft tissue and cardiac therapies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback